- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00379535
Preventing Lack of Iodine During Pregnancy
October 10, 2011 updated by: University Hospital, Toulouse
Phase III : Preventing Lack of Iodine During Pregnancy. Effect of Supplying Woman With Potassium Iodine to the Neuro-Cognitive Children Development Until Two Years
The purpose of this study is to evaluate the efficacy of potassium iodide during pregnancy on neuro-cognitive development of children followed up until two years.
Study Overview
Status
Terminated
Conditions
Intervention / Treatment
Detailed Description
374 patients with pregnancy less 12 weeks amenorrhea
Patients randomized in 2 parallel groups (each group with 187 patients)
- one group with 200 µg of potassium iodide
- one group with placebo
Follow up during 3 years with :
- a selection visit, an inclusion with randomization before 12 weeks amenorrhea
- and follow up visit at the 5th month and 8th month of pregnancy, the day of birth, and 6, 12, and 24 months " post partum "
Study Type
Interventional
Enrollment (Anticipated)
374
Phase
- Phase 3
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Toulouse, France, 31059
- Endocrinology - University Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 40 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Patients with pregnancy less 12 weeks amenorrhea , with clinically normal pregnancy, unique or twiny
- Patients who agree to take part in the study and able to sign an Informed Consent Form
Exclusion Criteria:
- Patients receiving a treatment for thyroid affection, or with thyroid pathology
- Patients with a chronic pathology like insulin dependent diabetes or arterial hypertension
- Patients with a treatment supplying iodine or having had a gynecologic exam with a iodine solution in the last 30 days
- Patients taking part in another clinical test or in the last 30 days
- Patients with depressive antecedent before pregnancy or taking antidepressant treatment
- Psychiatric troubles that may interfere with the clinical evaluation
- Patients under special supervision or trusteeship
- No social security cover
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: 1
Daily dose of 200 µg of potassium iodide
|
per os
Other Names:
|
Placebo Comparator: 2
Daily dose of placebo
|
per os
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Supplying a daily dose of 200 µg of potassium iodide in comparison with a placebo dose to pregnant woman and evaluate the impact on neuro-cognitive development of children followed up until two years
Time Frame: 2 years
|
2 years
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Prevalence of hypothyroxinemia and hypothyroidism during pregnancy
Time Frame: 9 months max
|
9 months max
|
Change in the functional thyroid parameters of mother during iodine treatment
Time Frame: 2 years
|
2 years
|
Comparison of the psychometric development of children , for woman with and without treatment
Time Frame: 6, 12, and 24 months
|
6, 12, and 24 months
|
Quantify the iodine supply from the woman to the baby during the breast feeding for woman with and without iodine treatment
Time Frame: 3 months
|
3 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: CARON PHILIPPE, Pr, CHU Toulouse
- Study Chair: WEMEAU Jean-Louis, Pr, CHRU Lille
- Study Chair: NICCOLI-SIRE Patricia, Pr, CHU Timone MARSEILLE
- Study Chair: BRUCKER-DAVIS Francoise, Dr, CHU Nice
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Caron P, Hoff M, Bazzi S, Dufor A, Faure G, Ghandour I, Lauzu P, Lucas Y, Maraval D, Mignot F, Ressigeac P, Vertongen F, Grange V. Urinary iodine excretion during normal pregnancy in healthy women living in the southwest of France: correlation with maternal thyroid parameters. Thyroid. 1997 Oct;7(5):749-54. doi: 10.1089/thy.1997.7.749.
- Caron Ph, D Glinoer La fonction thyroïdienne au cours de la grossesse La Thyroïde. De la physiologie cellulaire aux dysfonctionnements. Des concepts à la pratique. Ed Expansion Scientifique - Paris, 2001, 495-500.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
December 1, 2006
Primary Completion (Actual)
December 1, 2008
Study Completion (Actual)
June 1, 2010
Study Registration Dates
First Submitted
September 21, 2006
First Submitted That Met QC Criteria
September 21, 2006
First Posted (Estimate)
September 22, 2006
Study Record Updates
Last Update Posted (Estimate)
October 12, 2011
Last Update Submitted That Met QC Criteria
October 10, 2011
Last Verified
October 1, 2011
More Information
Terms related to this study
Other Study ID Numbers
- 0501101
- PHRC (2001/1939)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pregnancy
-
Far Eastern Memorial HospitalCompletedCornual PregnancyTaiwan
-
Peking Union Medical College HospitalPeking Union Medical CollegeUnknownPregnancy | Pregnancy Related | Infant | Pregnancy Disease | Risk FactorChina
-
Ufuk UniversityNot yet recruitingPregnancy Complications | Pregnancy Loss | Pregnancy Preterm
-
Hadassah Medical OrganizationCompleted
-
Centre Hospitalier Universitaire de Saint EtienneCompletedProlonged PregnancyFrance
-
University Hospital, ToursCompleted
-
Technische Universität DresdenWithdrawnPregnancy Trimester, Second | Pregnancy Trimester, First | Pregnancy Trimester, ThirdGermany
-
Turku University HospitalUniversity of TurkuCompleted
-
Universitair Ziekenhuis BrusselMerck Serono International SAUnknownPregnancy | Pregnancy LossBelgium
-
Hopital Antoine BeclereUnknown
Clinical Trials on potassium iodide
-
Prof. Gerasimos SykiotisNot yet recruiting
-
Columbia UniversityCompletedGraves DiseaseUnited States
-
University of Massachusetts, WorcesterCompletedGraves Disease | HyperthyroidismUnited States
-
Kyushu UniversityCompleted
-
Cairo UniversityNot yet recruiting
-
University of RzeszowCompleted
-
Stanford UniversityGlaxoSmithKlineTerminatedLymphoma, Non-HodgkinUnited States
-
University of GlasgowNot yet recruitingIodine Bioavailability
-
Jan CalissendorffRecruiting